Relationship of asprosin and diabetes: a meta-analysis

Abstract Background Diabetes characterized by chronic hyperglycemia, has become a serious hazard to human health in the recent decades. Previous research suggests that asprosin may contribute to the development of diabetes by regulating glucose homeostasis, appetite, insulin secretion, and insulin s...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiandong Zeng, Xin Sun, Wei He, Jing Xie, Caihong Xin
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12902-025-01843-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585654812278784
author Xiandong Zeng
Xin Sun
Wei He
Jing Xie
Caihong Xin
author_facet Xiandong Zeng
Xin Sun
Wei He
Jing Xie
Caihong Xin
author_sort Xiandong Zeng
collection DOAJ
description Abstract Background Diabetes characterized by chronic hyperglycemia, has become a serious hazard to human health in the recent decades. Previous research suggests that asprosin may contribute to the development of diabetes by regulating glucose homeostasis, appetite, insulin secretion, and insulin sensitivity. Although some studies have shown that asprosin levels are higher in patients with diabetes than in healthy individuals, the association between asprosin levels and diabetes remains controversial. Aim This meta-analysis aimed to assess asprosin levels in patients with diabetes and in healthy individuals. Methods We searched the following electronic databases: Web of Science, ScienceDirect, PubMed, and Willy. The title or abstract uses the following search term: “diabetes” is used in combination with the term “asprosin.” The meta-analysis results are presented as standardized mean differences (SMDs) with corresponding 95% confidence intervals (CIs). Results Fourteen articles were included in this meta-analysis. In our meta-analysis, the asprosin level in patients with diabetes was significantly higher than that in healthy controls (SMD: 0.95, 95% CI [0.66, 1.24]). Moreover, there was a significant difference in the asprosin levels between patients with diabetes without complication and those with complication (SMD: 0.81, 95% CI [0.33, 1.29]). Conclusions This systematic review is the first to evaluate the relationship between asprosin levels and diabetes. The asprosin levels were significantly higher in patients with diabetes. Clinical trial number Not applicable.
format Article
id doaj-art-a20039e1744748b08df5059fe29f0952
institution Kabale University
issn 1472-6823
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj-art-a20039e1744748b08df5059fe29f09522025-01-26T12:37:33ZengBMCBMC Endocrine Disorders1472-68232025-01-012511910.1186/s12902-025-01843-1Relationship of asprosin and diabetes: a meta-analysisXiandong Zeng0Xin Sun1Wei He2Jing Xie3Caihong Xin4Department of Oncological Surgery, Fourth People’s Hospital of ShenyangDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Soochow UniversityDepartment of Endocrinology and Metabolism, People’s Hospital of Liaoning ProvinceDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Soochow UniversityDepartment of Endocrinology and Metabolism, Fourth People’s Hospital of ShenyangAbstract Background Diabetes characterized by chronic hyperglycemia, has become a serious hazard to human health in the recent decades. Previous research suggests that asprosin may contribute to the development of diabetes by regulating glucose homeostasis, appetite, insulin secretion, and insulin sensitivity. Although some studies have shown that asprosin levels are higher in patients with diabetes than in healthy individuals, the association between asprosin levels and diabetes remains controversial. Aim This meta-analysis aimed to assess asprosin levels in patients with diabetes and in healthy individuals. Methods We searched the following electronic databases: Web of Science, ScienceDirect, PubMed, and Willy. The title or abstract uses the following search term: “diabetes” is used in combination with the term “asprosin.” The meta-analysis results are presented as standardized mean differences (SMDs) with corresponding 95% confidence intervals (CIs). Results Fourteen articles were included in this meta-analysis. In our meta-analysis, the asprosin level in patients with diabetes was significantly higher than that in healthy controls (SMD: 0.95, 95% CI [0.66, 1.24]). Moreover, there was a significant difference in the asprosin levels between patients with diabetes without complication and those with complication (SMD: 0.81, 95% CI [0.33, 1.29]). Conclusions This systematic review is the first to evaluate the relationship between asprosin levels and diabetes. The asprosin levels were significantly higher in patients with diabetes. Clinical trial number Not applicable.https://doi.org/10.1186/s12902-025-01843-1AsprosinDiabetesMeta-analysis
spellingShingle Xiandong Zeng
Xin Sun
Wei He
Jing Xie
Caihong Xin
Relationship of asprosin and diabetes: a meta-analysis
BMC Endocrine Disorders
Asprosin
Diabetes
Meta-analysis
title Relationship of asprosin and diabetes: a meta-analysis
title_full Relationship of asprosin and diabetes: a meta-analysis
title_fullStr Relationship of asprosin and diabetes: a meta-analysis
title_full_unstemmed Relationship of asprosin and diabetes: a meta-analysis
title_short Relationship of asprosin and diabetes: a meta-analysis
title_sort relationship of asprosin and diabetes a meta analysis
topic Asprosin
Diabetes
Meta-analysis
url https://doi.org/10.1186/s12902-025-01843-1
work_keys_str_mv AT xiandongzeng relationshipofasprosinanddiabetesametaanalysis
AT xinsun relationshipofasprosinanddiabetesametaanalysis
AT weihe relationshipofasprosinanddiabetesametaanalysis
AT jingxie relationshipofasprosinanddiabetesametaanalysis
AT caihongxin relationshipofasprosinanddiabetesametaanalysis